Literature DB >> 32740633

Failure of Free Flaps in Head and Neck Oncology Surgery in COVID-19 Patients.

Nadia Benmoussa1, Quitterie de Kerangal2, Nicolas Leymarie2, Ingrid Breuskin1, Tiffany Rigal1, Heba Alkhashnam2, Alexandre Tendron3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32740633     DOI: 10.1097/PRS.0000000000007120

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


× No keyword cloud information.
  6 in total

1.  Warning on coagulopathy COVID-19 related in microsurgical procedures.

Authors:  Maria Lucia Mangialardi; Liliana Barone Adesi; Marzia Salgarello; Ilaria Baldelli; Edoardo Raposio
Journal:  Microsurgery       Date:  2021-04-14       Impact factor: 2.080

2.  COVID-19 and rhinological surgery.

Authors:  Rushi Patel; Christina H Fang; Jordon G Grube; Jean Anderson Eloy; Wayne D Hsueh
Journal:  Oper Tech Otolayngol Head Neck Surg       Date:  2022-04-28

3.  Factors affecting the mortality of patients with COVID-19 undergoing surgery and the safety of medical staff: A systematic review and meta-analysis.

Authors:  Kun Wang; Changshuai Wu; Jian Xu; Baohui Zhang; Xiaowang Zhang; Zhenglian Gao; Zhengyuan Xia
Journal:  EClinicalMedicine       Date:  2020-11-04

4.  Two Cases of Impaired Wound Healing Among Patients With Major Head and Neck Free-Flap Reconstruction in the Setting of COVID-19 Infection.

Authors:  Daniel Inouye; Sheng Zhou; Bhavishya Clark; Mark Swanson; Tamara Chambers
Journal:  Cureus       Date:  2021-12-01

5.  Objectifying Priority Scoring and Shared Decision-Making in Head and Neck Cancer Reconstructive Surgery during the COVID-19 Pandemic: From Theory to Practice.

Authors:  Konstantinos Gasteratos; Stamatis Sapountzis
Journal:  Plast Reconstr Surg       Date:  2022-05-24       Impact factor: 5.169

Review 6.  What is the best treatment option for head and neck cancers in COVID-19 pandemic? A rapid review.

Authors:  Abolfazl Salari; Amirmohsen Jalaeefar; Mohammad Shirkhoda
Journal:  Am J Otolaryngol       Date:  2020-09-18       Impact factor: 1.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.